Table 4.
Association of 2-hour post-CPB urinary biomarker level with development of AKI
| Predictor variable | OR | 95% CI | P value |
|---|---|---|---|
| Unadjusted | |||
| KIM-1 | 1.96 | 1.26, 3.05 | 0.003 |
| NAG | 1.40 | 0.96, 2.06 | 0.08 |
| NGAL | 1.01 | 0.87, 1.16 | 0.93 |
| IL-18 | 1.38 | 1.02, 1.88 | 0.04 |
| Cystatin C | 1.02 | 0.75, 1.39 | 0.88 |
| α-1 microglobulin | 1.33 | 0.88, 2.01 | 0.17 |
| Adjusted for preoperative CCF score | |||
| KIM-1 | 1.69 | 1.10, 2.59 | 0.02 |
| NAG | 1.25 | 0.83 1.90 | 0.29 |
| IL-18 | 1.29 | 0.92, 1.82 | 0.14 |
| Adjusted for intraoperative CPB perfusion time | |||
| KIM-1 | 1.86 | 1.20, 2.89 | 0.006 |
| NAG | 1.27 | 0.84, 1.91 | 0.25 |
| IL-18 | 1.28 | 0.91, 1.78 | 0.15 |
Logistic regression models were generated to indicate odds ratios per doubling in the urinary biomarker level; OR denotes odds ratio; CI confidence interval; CPB, cardiopulmonary bypass; and CCF, Cleveland Clinic Foundation.